Robert F.

About Robert F.

Finding New Hope for Devastating Brain Diseases: I am a molecular neuroscientist and biotech entrepreneur focused on developing breakthrough medicines for complex neurological diseases. With a proven track record in scientific innovation and program leadership, I work at the forefront of target validation, translational research, and clinical development.As Founder and CEO of BrainStorm Therapeutics, Inc, I lead the development of a precision medicine platform that uses human disease models and advanced AI to discover therapeutic candidates targeting the critical molecular events driving neurodegeneration and synaptic dysfunction. By focusing on genetically validated, human-specific disease drivers, we are building a robust therapeutic pipeline with the potential to transform care for millions affected by debilitating neurological disorders. Our work has been recognized by the California Life Sciences 2025 Pantheon Award in the “AI Catalyst for Health Category” and the NVIDIA Award for our Parkinson’s Disease AI foundation model.https://blogs.nvidia.com/blog/brain-disease-ai-lab-in-the-loop/https://info.califesciences.org/hubfs/Insights%20Magazine/Life%20Sciences%20Insights%20-%20August%202025.pdf#page=16

Experience

1. Founder and CEO

   Brainstorm Therapeutics, Inc

   Mar 2023 — Present · San Diego, CA, US

   Pioneering the Future of CNS Drug Development: BrainStorm Therapeutics is an NIH- and NSF-funded, award-winning R&D team recognized by NVIDIA, California Life Sciences, and Biocom. We are driving innovation in CNS drug discovery through a human brain organoid platform that integrates experimental and computational approaches to develop disease-modifying therapies for neurological disorders.We are also pioneering a new economic model for biotech by using human-derived data to stratify patients early, identify likely responders, and design smaller, faster clinical trials—reducing risk, eliminating non-responders, and cutting the cost of failure that has historically wasted billions in drug development.

Education

• Columbia University Vagelos College of Physicians and Surgeons

  Postdoctoral Fellowship, Molecular Neuroscience

• The George Washington University School of Medicine and Health Sciences

  PhD Biochemistry, Neuropeptide receptors

• University of California, San Francisco

  Sabbatical, Excitatory neurotransmission

Skills

• Cell
• Drug Discovery
• High Throughput Screening
• Neurodegeneration
• Gpcrs
• Molecular Pharmacology
• In Vitro
• Biomarker Discovery
• Cell Biology
• Pharmaceutical Industry
• Neuroscience
• Clinical Research
• Biology
• Assay Development
• Thought Leadership
• Biochemistry
• Molecular Biology
• Protein Chemistry
• Pharmacology
• Cell Culture
• Validation
• Science
• Translational Medicine
• Antibodies
• Biotechnology
• Life Sciences
• In Vivo
• Signal Transduction
• Drug Development
• Biopharmaceuticals
• Cross-Functional Team Leadership
• Translational Research
• Small Molecules
• Biomarkers